Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.14 trillion and total revenue of $110.17 billion.
Market Cap
1.14T
Revenue
110.17B
Profits
-39.7B
PE Ratio
n/a
Profit Margin
-36.03%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.64B | 0.64% | 1,040,780 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.80B | -0.99% | 594,516 | 14.34B |
| 3 | ARGX | argenx SE | 49.22B | 1.97% | 298,708 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.61B | -1.82% | 1,119,200 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 34.75B | 0.39% | 142,244 | 5.34B |
| 6 | INSM | Insmed Incorporated | 34.45B | -0.37% | 1,563,956 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 27.86B | 0.84% | 2,220,559 | 2.38B |
| 8 | BNTX | BioNTech SE | 23.26B | -0.11% | 761,672 | 3.37B |
| 9 | ROIV | Roivant Sciences Ltd. | 20.38B | 1.10% | 4,076,138 | 13.31M |
| 10 | MRNA | Moderna, Inc. | 20.34B | -1.57% | 4,436,032 | 1.94B |
| 11 | INCY | Incyte Corporation | 19.30B | 1.12% | 1,089,327 | 5.14B |
| 12 | RVMD | Revolution Medicines, Inc. | 19.07B | -0.55% | 1,283,119 | - |
| 13 | GMAB | Genmab A/S | 17.32B | -0.42% | 2,026,563 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 14.97B | 2.66% | 1,868,282 | - |
| 15 | ASND | Ascendis Pharma A/S | 14.93B | 3.65% | 882,425 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.64B | 1.86% | 2,410,752 | 502.08M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.63B | 1.93% | 1,200,815 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.20B | 1.13% | 946,607 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.03B | 0.88% | 268,889 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.79B | 2.74% | 1,813,072 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.83B | -1.57% | 1,048,297 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.77B | 5.66% | 1,058,802 | 5.37M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.27B | 2.91% | 1,422,793 | 1.09B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.15B | 3.30% | 985,996 | 638.50M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 8.92B | 0.01% | 293,415 | 7.46M |
| 26 | PCVX | Vaxcyte, Inc. | 8.88B | 2.65% | 1,213,132 | - |
| 27 | TECH | Bio-Techne Corporation | 8.69B | 0.65% | 2,239,494 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.22B | -0.43% | 396,733 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 7.96B | -1.79% | 1,364,665 | 88.04M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.95B | 2.52% | 1,259,411 | 1.40B |
| 31 | IBRX | ImmunityBio, Inc. | 7.72B | 7.16% | 21,609,774 | 113.29M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.60B | -2.23% | 228,200 | 389.13M |
| 33 | BLTE | Belite Bio, Inc | 7.13B | 1.44% | 162,751 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 7.13B | 0.25% | 510,028 | 39.21M |
| 35 | ACLX | Arcellx, Inc. | 6.74B | 0.01% | 469,608 | 22.29M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.64B | 1.95% | 699,455 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.39B | 4.09% | 770,216 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.58% | 1,964,725 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.07B | -0.19% | 11,827,271 | - |
| 40 | CELC | Celcuity Inc. | 6.02B | 6.58% | 1,119,766 | - |
| 41 | COGT | Cogent Biosciences, Inc. | 6.02B | 1.08% | 2,473,044 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.97B | 1.02% | 439,117 | 521.31M |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.88B | 0.76% | 604,248 | 189.76M |
| 44 | PTCT | PTC Therapeutics, Inc. | 5.86B | -0.58% | 1,041,166 | 1.73B |
| 45 | CGON | CG Oncology, Inc. | 5.79B | -0.45% | 897,045 | 4.04M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.65B | -1.60% | 1,317,523 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.59B | 1.82% | 764,411 | 7.50M |
| 48 | CAI | Caris Life Sciences, Inc. | 5.43B | -1.59% | 2,099,769 | 812.03M |
| 49 | ERAS | Erasca, Inc. | 5.40B | 2.48% | 3,430,136 | - |
| 50 | IMVT | Immunovant, Inc. | 5.22B | 3.72% | 1,847,578 | - |
| 51 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | -0.10% | 7,061,520 | 1.00B |
| 52 | TGTX | TG Therapeutics, Inc. | 5.11B | 1.23% | 1,526,724 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.96B | -0.08% | 1,097,520 | 3.51M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.85B | 4.78% | 652,572 | 2.04M |
| 55 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.07% | 2,735,617 | 634.21M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.49B | 0.91% | 925,444 | 761.41M |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.15B | -0.83% | 857,747 | 7.70M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 4.10B | -1.18% | 258,091 | 268.09M |
| 59 | SYRE | Spyre Therapeutics, Inc. | 4.07B | -0.40% | 585,552 | - |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.05B | 3.80% | 2,064,000 | - |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 4.03B | 3.12% | 426,320 | 22.50M |
| 62 | GPCR | Structure Therapeutics Inc. | 3.91B | 3.82% | 589,452 | - |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.85B | 0.04% | 1,229,430 | 1.07B |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.60B | 1.45% | 575,000 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.37B | -0.55% | 1,551,139 | 1.03B |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.27B | 0.20% | 135,080 | 803.79M |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.19B | 5.33% | 2,004,221 | - |
| 68 | ORKA | Oruka Therapeutics, Inc. | 3.15B | 2.56% | 836,953 | - |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.13B | 1.15% | 1,534,414 | 588.99M |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.08B | 0.74% | 234,830 | 451.36M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.06B | -1.68% | 1,435,396 | - |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | -0.16% | 837,936 | 376.07M |
| 73 | TNGX | Tango Therapeutics, Inc. | 2.95B | 3.19% | 2,907,659 | 62.38M |
| 74 | VERA | Vera Therapeutics, Inc. | 2.92B | 1.49% | 1,643,305 | - |
| 75 | RCUS | Arcus Biosciences, Inc. | 2.92B | 2.78% | 565,755 | 247.00M |
| 76 | ALMS | Alumis Inc. | 2.92B | 1.01% | 975,130 | 24.05M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.90B | -0.76% | 1,851,575 | 490.73M |
| 78 | ELVN | Enliven Therapeutics, Inc. | 2.73B | 6.20% | 2,269,893 | - |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.72B | 0.13% | 1,416,047 | 218.71M |
| 80 | SLNO | Soleno Therapeutics, Inc. | 2.72B | -0.17% | 6,384,292 | 190.41M |
| 81 | RLAY | Relay Therapeutics, Inc. | 2.68B | 3.38% | 3,079,703 | 15.36M |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.64B | 3.73% | 815,378 | 1.55M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.61B | 3.50% | 2,010,680 | 139.74M |
| 84 | KOD | Kodiak Sciences Inc. | 2.61B | 1.34% | 628,866 | - |
| 85 | IRON | Disc Medicine, Inc. | 2.57B | 1.55% | 321,530 | - |
| 86 | IMNM | Immunome, Inc. | 2.54B | 3.50% | 888,285 | 6.94M |
| 87 | ADMA | ADMA Biologics, Inc. | 2.37B | 1.12% | 4,797,492 | 510.17M |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.35B | 3.28% | 1,968,256 | 673.00M |
| 89 | ZLAB | Zai Lab Limited | 2.34B | -3.04% | 1,035,946 | 460.16M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | 1.51% | 1,884,660 | 2.20B |
| 91 | AAPG | Ascentage Pharma Group International | 2.32B | -2.56% | 1,648 | 82.08M |
| 92 | MANE | Veradermics, Incorporated | 2.24B | 3.34% | 142,609 | - |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.24B | -2.13% | 1,035,439 | - |
| 94 | NKTR | Nektar Therapeutics | 2.23B | 3.69% | 456,183 | 55.23M |
| 95 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.19% | 1,326,354 | 158.18M |
| 96 | SNDX | Syndax Pharmaceuticals, Inc. | 2.18B | 0.81% | 708,765 | 172.35M |
| 97 | DFTX | Definium Therapeutics, Inc. | 2.14B | 1.90% | 1,561,457 | - |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | 0.44% | 954,225 | 283.06M |
| 99 | STOK | Stoke Therapeutics, Inc. | 2.08B | 0.80% | 493,178 | 184.42M |
| 100 | ADPT | Adaptive Biotechnologies Corporation | 2.06B | -9.70% | 1,739,995 | 276.98M |
| 101 | OCUL | Ocular Therapeutix, Inc. | 2.02B | 10.45% | 5,116,376 | 51.95M |
| 102 | ZYME | Zymeworks Inc. | 2.02B | 2.40% | 396,726 | 105.97M |
| 103 | TYRA | Tyra Biosciences, Inc. | 1.98B | -1.19% | 1,005,758 | - |
| 104 | ANAB | AnaptysBio, Inc. | 1.97B | 4.58% | 373,092 | 234.60M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 1.93B | -2.52% | 867,783 | 54.03M |
| 106 | GLPG | Galapagos NV | 1.88B | -1.14% | 112,167 | 1.31B |
| 107 | PVLA | Palvella Therapeutics, Inc. | 1.86B | 5.71% | 356,737 | - |
| 108 | MESO | Mesoblast Limited | 1.85B | 4.53% | 344,853 | 65.38M |
| 109 | CAPR | Capricor Therapeutics, Inc. | 1.82B | 0.03% | 686,473 | 11.13M |
| 110 | INVA | Innoviva, Inc. | 1.79B | 2.46% | 657,637 | 411.33M |
| 111 | PHVS | Pharvaris N.V. | 1.77B | -1.78% | 105,956 | - |
| 112 | SION | Sionna Therapeutics, Inc. | 1.75B | 5.25% | 352,478 | - |
| 113 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | -2.36% | 8,762,396 | 74.68M |
| 114 | VCEL | Vericel Corporation | 1.71B | -1.29% | 347,982 | 276.26M |
| 115 | TRVI | Trevi Therapeutics, Inc. | 1.71B | 1.76% | 1,136,045 | - |
| 116 | HRMY | Harmony Biosciences Holdings, Inc. | 1.69B | 2.42% | 645,426 | 868.45M |
| 117 | NRIX | Nurix Therapeutics, Inc. | 1.68B | 4.10% | 1,191,089 | 71.78M |
| 118 | IOVA | Iovance Biotherapeutics, Inc. | 1.65B | 15.56% | 26,759,360 | 263.50M |
| 119 | RAPP | Rapport Therapeutics, Inc. | 1.64B | 1.57% | 198,150 | - |
| 120 | NTLA | Intellia Therapeutics, Inc. | 1.63B | -0.29% | 1,438,781 | 67.67M |
| 121 | IMCR | Immunocore Holdings plc | 1.61B | -0.13% | 289,048 | 400.02M |
| 122 | DMRA | Damora Therapeutics, Inc. | 1.61B | 4.26% | 337,183 | - |
| 123 | OCS | Oculis Holding AG | 1.61B | -0.55% | 104,233 | 1.51M |
| 124 | NUVB | Nuvation Bio Inc. | 1.59B | 2.21% | 1,973,585 | 62.90M |
| 125 | VRDN | Viridian Therapeutics, Inc. | 1.57B | 6.29% | 2,719,144 | 70.85M |
| 126 | VIR | Vir Biotechnology, Inc. | 1.57B | 3.26% | 2,107,560 | 68.56M |
| 127 | MBX | MBX Biosciences, Inc. | 1.56B | 3.79% | 467,259 | - |
| 128 | PGEN | Precigen, Inc. | 1.51B | 3.64% | 2,614,272 | 9.68M |
| 129 | ARDX | Ardelyx, Inc. | 1.50B | 0.49% | 2,581,218 | 407.32M |
| 130 | SVRA | Savara Inc. | 1.49B | -1.18% | 991,997 | - |
| 131 | GENB | Generate Biomedicines, Inc. | 1.47B | -3.43% | 205,381 | 31.89M |
| 132 | NBTX | Nanobiotix S.A. | 1.46B | -0.97% | 62,677 | 38.27M |
| 133 | OLMA | Olema Pharmaceuticals, Inc. | 1.45B | 6.05% | 1,017,249 | - |
| 134 | GLUE | Monte Rosa Therapeutics, Inc. | 1.44B | 5.43% | 870,683 | 123.67M |
| 135 | BCAX | Bicara Therapeutics Inc. | 1.44B | 1.71% | 653,937 | - |
| 136 | IMTX | Immatics N.V. | 1.43B | 1.23% | 356,734 | 56.67M |
| 137 | BHVN | Biohaven Ltd. | 1.41B | 0.11% | 1,393,206 | - |
| 138 | MLTX | MoonLake Immunotherapeutics | 1.39B | 4.35% | 1,695,395 | - |
| 139 | NVAX | Novavax, Inc. | 1.39B | 1.43% | 2,307,669 | 1.12B |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.39B | -0.75% | 855,031 | 2.50M |
| 141 | ATAI | AtaiBeckley Inc. | 1.35B | -1.60% | 2,061,766 | 4.09M |
| 142 | WVE | Wave Life Sciences Ltd. | 1.35B | 0.85% | 2,556,782 | 42.73M |
| 143 | TSHA | Taysha Gene Therapies, Inc. | 1.33B | 1.76% | 1,367,026 | 9.77M |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.32B | 5.31% | 678,693 | - |
| 145 | MPLT | MapLight Therapeutics, Inc. | 1.29B | 21.33% | 536,675 | - |
| 146 | ZBIO | Zenas BioPharma, Inc. | 1.27B | 2.01% | 554,217 | 10.00M |
| 147 | AVBP | ArriVent BioPharma, Inc. | 1.20B | 7.92% | 1,333,710 | - |
| 148 | PHAR | Pharming Group N.V. | 1.20B | - | 1,391 | 376.13M |
| 149 | EYPT | EyePoint, Inc. | 1.19B | 0.42% | 903,901 | 31.37M |
| 150 | DBVT | DBV Technologies S.A. | 1.17B | -0.51% | 117,672 | 5.64M |
| 151 | GERN | Geron Corporation | 1.13B | 2.92% | 17,943,694 | 183.88M |
| 152 | SEPN | Septerna, Inc. | 1.12B | 1.39% | 220,936 | 45.95M |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.11B | 12.84% | 509,111 | 1.30M |
| 154 | ABCL | AbCellera Biologics Inc. | 1.04B | 0.29% | 2,029,434 | 75.13M |
| 155 | ORIC | ORIC Pharmaceuticals, Inc. | 1.04B | 14.70% | 2,389,585 | - |
| 156 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | 1.52% | 1,604,290 | 291.85M |
| 157 | EVMN | Evommune, Inc. | 1.03B | 5.60% | 285,748 | 13.00M |
| 158 | KALV | KalVista Pharmaceuticals, Inc. | 1.02B | 3.53% | 582,182 | 73.62M |
| 159 | QURE | uniQure N.V. | 1.02B | 2.58% | 1,051,508 | 16.10M |
| 160 | PHAT | Phathom Pharmaceuticals, Inc. | 1.00B | 7.03% | 1,676,074 | 175.11M |
| 161 | URGN | UroGen Pharma Ltd. | 999.45M | 7.49% | 1,158,016 | 109.79M |
| 162 | ANNX | Annexon, Inc. | 985.31M | 1.49% | 1,301,644 | - |
| 163 | CMPX | Compass Therapeutics, Inc. | 981.48M | 0.93% | 2,686,303 | 850.00K |
| 164 | IVA | Inventiva S.A. | 979.97M | 2.94% | 335,652 | 9.31M |
| 165 | AKTS | Aktis Oncology, Inc. | 976.73M | 4.06% | 292,399 | 6.50M |
| 166 | GHRS | GH Research PLC | 947.19M | 1.87% | 51,321 | - |
| 167 | CGEM | Cullinan Therapeutics, Inc. | 920.60M | 1.67% | 551,032 | - |
| 168 | XNCR | Xencor, Inc. | 918.93M | 2.29% | 1,013,458 | 125.58M |
| 169 | CTMX | CytomX Therapeutics, Inc. | 916.59M | -0.24% | 3,958,088 | 76.20M |
| 170 | SLS | SELLAS Life Sciences Group, Inc. | 906.89M | 3.91% | 5,493,481 | - |
| 171 | JBIO | Jade Biosciences, Inc. | 899.04M | 8.77% | 1,235,022 | - |
| 172 | JANX | Janux Therapeutics, Inc. | 883.88M | - | 627,737 | 10.00M |
| 173 | FTRE | Fortrea Holdings Inc. | 877.03M | -2.54% | 736,771 | 2.72B |
| 174 | OMER | Omeros Corporation | 857.47M | 3.48% | 1,278,942 | - |
| 175 | TBPH | Theravance Biopharma, Inc. | 852.21M | -0.30% | 301,674 | 107.46M |
| 176 | VOR | Vor Biopharma Inc. | 845.30M | -0.95% | 954,650 | - |
| 177 | ABUS | Arbutus Biopharma Corporation | 840.56M | -1.83% | 1,870,856 | 14.08M |
| 178 | SANA | Sana Biotechnology, Inc. | 832.62M | -2.80% | 1,603,560 | - |
| 179 | SPRY | ARS Pharmaceuticals, Inc. | 821.19M | 0.98% | 2,107,816 | 84.28M |
| 180 | DRUG | Bright Minds Biosciences Inc. | 805.65M | 3.81% | 241,733 | - |
| 181 | MRVI | Maravai LifeSciences Holdings, Inc. | 799.48M | - | 1,460,728 | 185.74M |
| 182 | RLMD | Relmada Therapeutics, Inc. | 798.20M | 8.56% | 1,559,821 | - |
| 183 | SLDB | Solid Biosciences Inc. | 796.97M | 1.00% | 723,969 | - |
| 184 | MNKD | MannKind Corporation | 788.74M | -1.92% | 3,291,187 | 348.97M |
| 185 | KURA | Kura Oncology, Inc. | 781.72M | 0.68% | 764,467 | 67.48M |
| 186 | DSGN | Design Therapeutics, Inc. | 770.29M | -1.42% | 203,915 | - |
| 187 | MGTX | MeiraGTx Holdings plc | 760.71M | -0.53% | 404,925 | 81.39M |
| 188 | TENX | Tenax Therapeutics, Inc. | 752.49M | -0.60% | 1,164,163 | - |
| 189 | LXRX | Lexicon Pharmaceuticals, Inc. | 745.68M | 5.39% | 3,947,866 | 49.80M |
| 190 | ANRO | Alto Neuroscience, Inc. | 715.58M | 3.18% | 194,049 | - |
| 191 | ARVN | Arvinas, Inc. | 714.44M | -0.36% | 455,257 | 262.60M |
| 192 | ALLO | Allogene Therapeutics, Inc. | 709.39M | 7.78% | 4,859,264 | 22.00K |
| 193 | SGP | SpyGlass Pharma, Inc. | 709.31M | -4.50% | 62,359 | - |
| 194 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 708.69M | 2.49% | 353,915 | - |
| 195 | LBRX | LB Pharmaceuticals Inc | 665.11M | 1.19% | 317,296 | - |
| 196 | GYRE | Gyre Therapeutics, Inc. | 661.11M | 2.12% | 34,198 | 116.59M |
| 197 | DRTS | Alpha Tau Medical Ltd. | 646.87M | 2.08% | 280,371 | - |
| 198 | FBRX | Forte Biosciences, Inc. | 636.24M | 29.04% | 2,741,869 | - |
| 199 | CBIO | Crescent Biopharma, Inc. | 634.39M | 4.26% | 121,131 | 10.84M |
| 200 | OCGN | Ocugen, Inc. | 631.87M | 0.54% | 5,801,664 | 4.41M |
| 201 | PRME | Prime Medicine, Inc. | 621.55M | -0.85% | 1,130,063 | 4.63M |
| 202 | MDXG | MiMedx Group, Inc. | 598.72M | 1.51% | 1,376,054 | 418.63M |
| 203 | TECX | Tectonic Therapeutic, Inc. | 583.77M | 3.43% | 167,077 | - |
| 204 | CRMD | CorMedix Inc. | 581.81M | 1.80% | 723,307 | 311.71M |
| 205 | KYTX | Kyverna Therapeutics, Inc. | 579.16M | 3.90% | 690,351 | - |
| 206 | PROK | ProKidney Corp. | 573.64M | 2.70% | 538,503 | 893.00K |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 570.09M | 1.25% | 671,550 | 106.47M |
| 208 | PRTA | Prothena Corporation plc | 569.55M | -0.66% | 414,710 | 9.68M |
| 209 | ACRS | Aclaris Therapeutics, Inc. | 567.10M | 3.29% | 1,064,157 | 7.83M |
| 210 | UPB | Upstream Bio, Inc. | 567.06M | 5.89% | 813,219 | 2.85M |
| 211 | RIGL | Rigel Pharmaceuticals, Inc. | 563.62M | 2.62% | 368,069 | 294.28M |
| 212 | LYEL | Lyell Immunopharma, Inc. | 556.38M | 4.10% | 122,142 | 36.00K |
| 213 | VALN | Valneva SE | 534.59M | -1.76% | 15,968 | 205.07M |
| 214 | ZURA | Zura Bio Limited | 531.33M | -1.75% | 563,244 | - |
| 215 | STTK | Shattuck Labs, Inc. | 529.58M | 5.41% | 987,427 | 1.00M |
| 216 | LRMR | Larimar Therapeutics, Inc. | 528.76M | - | 1,401,885 | - |
| 217 | FULC | Fulcrum Therapeutics, Inc. | 526.81M | 0.13% | 600,696 | 80.00M |
| 218 | IMMX | Immix Biopharma, Inc. | 516.87M | 11.43% | 943,945 | - |
| 219 | TRDA | Entrada Therapeutics, Inc. | 505.80M | -1.89% | 144,538 | 25.42M |
| 220 | IVVD | Invivyd, Inc. | 503.39M | 31.85% | 12,983,338 | 53.43M |
| 221 | FDMT | 4D Molecular Therapeutics, Inc. | 502.35M | -2.57% | 389,094 | 85.21M |
| 222 | AGMB | AgomAb Therapeutics NV | 497.60M | 3.65% | 193,355 | - |
| 223 | VSTM | Verastem, Inc. | 491.00M | 2.57% | 1,375,984 | 30.91M |
| 224 | REPL | Replimune Group, Inc. | 488.00M | 0.34% | 8,356,467 | - |
| 225 | EIKN | Eikon Therapeutics, Inc. | 487.79M | -5.16% | 245,699 | - |
| 226 | ENGN | enGene Holdings Inc. | 487.01M | -0.55% | 186,018 | - |
| 227 | CTNM | Contineum Therapeutics, Inc. | 479.02M | 0.31% | 123,167 | - |
| 228 | ADCT | ADC Therapeutics SA | 477.69M | 0.80% | 630,057 | 81.36M |
| 229 | LXEO | Lexeo Therapeutics, Inc. | 476.38M | -0.16% | 531,935 | - |
| 230 | ASMB | Assembly Biosciences, Inc. | 473.50M | 1.70% | 113,378 | 72.30M |
| 231 | AVIR | Atea Pharmaceuticals, Inc. | 465.28M | -1.52% | 252,024 | - |
| 232 | VTVT | vTv Therapeutics Inc. | 462.88M | -3.02% | 61,713 | 17.00K |
| 233 | RGNX | REGENXBIO Inc. | 462.49M | 3.34% | 470,902 | 170.44M |
| 234 | ABSI | Absci Corporation | 451.41M | -1.34% | 2,818,995 | 2.80M |
| 235 | STRO | Sutro Biopharma, Inc. | 443.34M | -1.07% | 186,803 | 102.48M |
| 236 | ANL | Adlai Nortye Ltd. | 442.80M | -0.25% | 717,776 | -1.35M |
| 237 | ALT | Altimmune, Inc. | 439.76M | 0.30% | 1,989,235 | 41.00K |
| 238 | XOMA | XOMA Royalty Corporation | 438.02M | 6.06% | 307,971 | 52.15M |
| 239 | AURA | Aura Biosciences, Inc. | 434.94M | 0.15% | 316,003 | - |
| 240 | EPRX | Eupraxia Pharmaceuticals Inc. | 433.75M | 2.91% | 129,565 | - |
| 241 | VNDA | Vanda Pharmaceuticals Inc. | 433.26M | 0.55% | 1,094,698 | 216.11M |
| 242 | ARMP | Armata Pharmaceuticals, Inc. | 422.38M | -4.87% | 35,315 | 4.90M |
| 243 | YDES | YD Bio Limited | 407.85M | 0.69% | 17,231 | 510.36K |
| 244 | IPSC | Century Therapeutics, Inc. | 406.17M | -1.31% | 1,618,517 | 109.16M |
| 245 | ENTA | Enanta Pharmaceuticals, Inc. | 404.82M | 1.31% | 108,334 | 66.98M |
| 246 | PBYI | Puma Biotechnology, Inc. | 396.84M | 3.86% | 338,203 | 228.37M |
| 247 | RCKT | Rocket Pharmaceuticals, Inc. | 392.84M | - | 2,396,947 | - |
| 248 | IRD | Opus Genetics, Inc. | 391.32M | 6.80% | 993,086 | 14.20M |
| 249 | AUTL | Autolus Therapeutics plc | 391.23M | -1.34% | 2,059,857 | 75.39M |
| 250 | MNPR | Monopar Therapeutics Inc. | 387.61M | -0.19% | 391,627 | - |
| 251 | PRTC | PureTech Health plc | 387.51M | 4.65% | 1,712 | 6.39M |
| 252 | NAUT | Nautilus Biotechnology, Inc. | 384.76M | -2.88% | 295,330 | - |
| 253 | CLYM | Climb Bio, Inc. | 384.53M | 13.38% | 572,366 | - |
| 254 | OVID | Ovid Therapeutics Inc. | 379.80M | 10.77% | 6,124,086 | 7.25M |
| 255 | RZLT | Rezolute, Inc. | 379.13M | 2.53% | 1,352,194 | - |
| 256 | NMRA | Neumora Therapeutics, Inc. | 378.65M | -4.59% | 849,569 | - |
| 257 | BNTC | Benitec Biopharma Inc. | 377.49M | -0.36% | 91,131 | - |
| 258 | DNA | Ginkgo Bioworks Holdings, Inc. | 374.27M | -6.54% | 918,334 | 170.16M |
| 259 | LCTX | Lineage Cell Therapeutics, Inc. | 371.14M | -3.25% | 1,019,625 | 14.56M |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 370.04M | 0.49% | 418,756 | 35.11M |
| 261 | IMRX | Immuneering Corporation | 365.94M | 2.91% | 875,883 | - |
| 262 | PRLD | Prelude Therapeutics Incorporated | 363.15M | 4.27% | 237,293 | 12.14M |
| 263 | NAGE | Niagen Bioscience, Inc. | 359.51M | -2.61% | 519,673 | 129.42M |
| 264 | GLSI | Greenwich LifeSciences, Inc. | 357.72M | 6.69% | 180,826 | - |
| 265 | CABA | Cabaletta Bio, Inc. | 352.89M | 2.59% | 1,912,143 | - |
| 266 | CADL | Candel Therapeutics, Inc. | 351.59M | -3.03% | 927,173 | - |
| 267 | BCYC | Bicycle Therapeutics plc | 345.75M | -0.40% | 276,156 | 72.59M |
| 268 | NGEN | NervGen Pharma Corp. | 340.72M | 0.72% | 154,142 | - |
| 269 | ACIU | AC Immune SA | 337.28M | 5.92% | 557,517 | 4.51M |
| 270 | DMAC | DiaMedica Therapeutics Inc. | 332.99M | -0.16% | 293,616 | - |
| 271 | NGNE | Neurogene Inc. | 332.82M | -1.11% | 104,172 | 925.00K |
| 272 | PALI | Palisade Bio, Inc. | 331.49M | 5.88% | 3,394,312 | - |
| 273 | AVTX | Avalo Therapeutics, Inc. | 323.82M | -1.39% | 1,046,397 | 59.00K |
| 274 | SRZN | Surrozen, Inc. | 315.31M | 5.86% | 85,871 | 3.48M |
| 275 | ZNTL | Zentalis Pharmaceuticals, Inc. | 313.52M | 60.14% | 15,874,760 | 26.87M |
| 276 | ABEO | Abeona Therapeutics Inc. | 292.09M | 5.13% | 1,989,285 | 5.82M |
| 277 | LENZ | LENZ Therapeutics, Inc. | 291.28M | -1.69% | 510,759 | 19.09M |
| 278 | IKT | Inhibikase Therapeutics, Inc. | 288.01M | -2.87% | 1,126,583 | 1.00 |
| 279 | TARA | Protara Therapeutics, Inc. | 287.19M | 1.72% | 483,196 | - |
| 280 | EDIT | Editas Medicine, Inc. | 282.85M | 4.71% | 1,355,722 | 40.52M |
| 281 | AVXL | Anavex Life Sciences Corp. | 282.65M | 0.33% | 795,270 | - |
| 282 | FHTX | Foghorn Therapeutics Inc. | 281.17M | -2.04% | 302,521 | 30.91M |
| 283 | NBP | NovaBridge Biosciences | 280.16M | -0.82% | 608,766 | - |
| 284 | CCCC | C4 Therapeutics, Inc. | 276.15M | -2.41% | 19,701,961 | 35.95M |
| 285 | SLN | Silence Therapeutics plc | 273.96M | -0.85% | 217,229 | 559.00K |
| 286 | PLYX | Polaryx Therapeutics, Inc. | 272.70M | 0.35% | 154,701 | - |
| 287 | SABS | SAB Biotherapeutics, Inc. | 269.16M | 2.68% | 235,245 | 114.70K |
| 288 | ALEC | Alector, Inc. | 264.87M | -0.83% | 278,536 | 21.05M |
| 289 | HELP | Cybin Inc. | 262.19M | -0.19% | 316,273 | - |
| 290 | NERV | Minerva Neurosciences, Inc. | 260.51M | 11.07% | 363,158 | - |
| 291 | CLLS | Cellectis S.A. | 257.82M | -0.85% | 7,290 | 79.59M |
| 292 | ADAG | Adagene Inc. | 254.05M | -3.87% | 622,292 | 7.67M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 247.54M | -0.94% | 120,140 | 33.48M |
| 294 | CHRS | Coherus Oncology, Inc. | 247.32M | -2.94% | 993,335 | 42.17M |
| 295 | MIST | Milestone Pharmaceuticals Inc. | 246.53M | 12.92% | 11,382,711 | 1.55M |
| 296 | KROS | Keros Therapeutics, Inc. | 246.27M | -0.48% | 336,969 | 244.06M |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 239.58M | -1.62% | 72,427 | 19.39M |
| 298 | CNTX | Context Therapeutics Inc. | 237.97M | -1.89% | 594,881 | - |
| 299 | VYGR | Voyager Therapeutics, Inc. | 236.01M | 1.02% | 648,899 | 40.37M |
| 300 | ELDN | Eledon Pharmaceuticals, Inc. | 235.50M | -0.96% | 995,113 | - |
| 301 | CGEN | Compugen Ltd. | 234.49M | 8.30% | 436,994 | 72.76M |
| 302 | ARCT | Arcturus Therapeutics Holdings Inc. | 233.64M | -3.29% | 333,491 | 82.03M |
| 303 | CAMP | Camp4 Therapeutics Corporation | 233.12M | -1.97% | 35,942 | 3.50M |
| 304 | MDWD | MediWound Ltd. | 228.38M | 2.90% | 81,355 | 16.96M |
| 305 | ENLV | Enlivex Ltd. | 225.42M | 1.77% | 234,034 | - |
| 306 | ALXO | ALX Oncology Holdings Inc. | 223.73M | -10.29% | 3,357,957 | - |
| 307 | FENC | Fennec Pharmaceuticals Inc. | 220.64M | -1.39% | 75,369 | 44.64M |
| 308 | MGNX | MacroGenics, Inc. | 218.63M | -0.29% | 769,743 | 149.50M |
| 309 | CDXS | Codexis, Inc. | 218.09M | 8.60% | 3,290,669 | 70.39M |
| 310 | OABI | OmniAb, Inc. | 217.90M | -0.99% | 248,493 | 18.67M |
| 311 | NVCT | Nuvectis Pharma, Inc. | 216.17M | 0.25% | 36,280 | - |
| 312 | PRQR | ProQR Therapeutics N.V. | 208.61M | 8.20% | 2,122,535 | 19.19M |
| 313 | MENS | Jyong Biotech Ltd. | 206.09M | - | 74,659 | - |
| 314 | CNTN | Canton Strategic Holdings, Inc. | 192.63M | 3.66% | 1,259,728 | - |
| 315 | CRBU | Caribou Biosciences, Inc. | 189.41M | 0.51% | 897,657 | 11.16M |
| 316 | ELTX | Elicio Therapeutics, Inc. | 189.30M | 1.58% | 99,013 | - |
| 317 | KRRO | Korro Bio, Inc. | 188.65M | -2.82% | 113,077 | 6.39M |
| 318 | TNXP | Tonix Pharmaceuticals Holding Corp. | 184.67M | -0.31% | 456,483 | 13.11M |
| 319 | KPTI | Karyopharm Therapeutics Inc. | 183.95M | 12.55% | 1,209,505 | 146.07M |
| 320 | SGMT | Sagimet Biosciences Inc. | 183.78M | 0.89% | 289,465 | - |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 183.70M | 1.33% | 876,777 | 52.74M |
| 322 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 183.04M | 4.88% | 199,829 | - |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 181.25M | -2.71% | 516,052 | - |
| 324 | ACHV | Achieve Life Sciences, Inc. | 176.76M | 1.84% | 519,778 | - |
| 325 | AGEN | Agenus Inc. | 170.87M | 5.95% | 1,159,775 | 114.20M |
| 326 | DTIL | Precision BioSciences, Inc. | 170.56M | 10.35% | 208,476 | 34.26M |
| 327 | IMUX | Immunic, Inc. | 168.30M | 8.40% | 1,578,090 | - |
| 328 | ARTV | Artiva Biotherapeutics, Inc. | 168.07M | 9.85% | 190,153 | 251.00K |
| 329 | UNCY | Unicycive Therapeutics, Inc. | 167.83M | 3.10% | 455,499 | - |
| 330 | WHWK | Whitehawk Therapeutics, Inc. | 167.55M | 4.11% | 282,949 | 7.15M |
| 331 | NKTX | Nkarta, Inc. | 166.82M | 1.30% | 439,312 | - |
| 332 | RNAC | Cartesian Therapeutics, Inc. | 163.83M | 0.49% | 174,837 | 2.80M |
| 333 | MOLN | Molecular Partners AG | 160.98M | 2.17% | 3,407 | 856.30K |
| 334 | SPRO | Spero Therapeutics, Inc. | 160.94M | 2.21% | 450,512 | 66.80M |
| 335 | TLSA | Tiziana Life Sciences Ltd | 160.81M | -0.79% | 126,226 | - |
| 336 | TNYA | Tenaya Therapeutics, Inc. | 160.58M | 2.04% | 3,806,308 | - |
| 337 | GALT | Galectin Therapeutics Inc. | 159.96M | 9.46% | 406,626 | - |
| 338 | CNTB | Connect Biopharma Holdings Limited | 157.13M | 5.70% | 273,192 | 64.00K |
| 339 | HRTX | Heron Therapeutics, Inc. | 154.49M | -1.51% | 1,638,485 | 154.90M |
| 340 | BDTX | Black Diamond Therapeutics, Inc. | 147.80M | 3.20% | 869,149 | 70.00M |
| 341 | FATE | Fate Therapeutics, Inc. | 147.65M | 7.63% | 1,469,047 | 6.65M |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 142.37M | 1.15% | 85,771 | 2.00M |
| 343 | KLRS | Kalaris Therapeutics, Inc. | 139.17M | -4.26% | 67,533 | - |
| 344 | ACOG | Alpha Cognition Inc. | 138.70M | -3.99% | 53,228 | 10.22M |
| 345 | HUMA | Humacyte, Inc. | 134.77M | -6.83% | 4,637,039 | 2.04M |
| 346 | BMEA | Biomea Fusion, Inc. | 133.75M | 5.11% | 2,241,681 | - |
| 347 | IPHA | Innate Pharma S.A. | 128.37M | - | 61,025 | 10.57M |
| 348 | HURA | TuHURA Biosciences, Inc. | 124.61M | 8.29% | 1,274,713 | - |
| 349 | NTHI | NeOnc Technologies Holdings, Inc. | 121.89M | -4.66% | 55,497 | 39.99K |
| 350 | ONCY | Oncolytics Biotech Inc. | 120.77M | 14.80% | 2,402,693 | - |
| 351 | EQ | Equillium, Inc. | 120.76M | 6.11% | 264,326 | 4.39M |
| 352 | CRDF | Cardiff Oncology, Inc. | 114.17M | 7.05% | 1,032,769 | 593.00K |
| 353 | GNLX | Genelux Corporation | 113.59M | -3.03% | 1,007,621 | 8.00K |
| 354 | PMN | ProMIS Neurosciences, Inc. | 112.10M | 16.82% | 48,182 | - |
| 355 | PEPG | PepGen Inc. | 111.28M | -3.01% | 1,249,838 | - |
| 356 | ANTX | AN2 Therapeutics, Inc. | 109.62M | -8.68% | 238,472 | - |
| 357 | SGMO | Sangamo Therapeutics, Inc. | 108.50M | 2.83% | 5,838,366 | 39.55M |
| 358 | COYA | Coya Therapeutics, Inc. | 106.26M | 10.22% | 342,711 | 7.95M |
| 359 | TTRX | Turn Therapeutics Inc. | 104.56M | 0.29% | 14,731 | - |
| 360 | KZIA | Kazia Therapeutics Limited | 103.98M | - | 118,743 | 1.27M |
| 361 | PYXS | Pyxis Oncology, Inc. | 101.16M | 9.52% | 807,270 | 13.86M |
| 362 | VRCA | Verrica Pharmaceuticals Inc. | 100.15M | 0.17% | 19,694 | 35.58M |
| 363 | EXOZ | eXoZymes, Inc. | 96.66M | 9.09% | 8,605 | -700.00 |
| 364 | CBUS | Cibus, Inc. | 95.98M | -13.99% | 842,391 | 3.64M |
| 365 | ALDX | Aldeyra Therapeutics, Inc. | 95.69M | 1.27% | 2,673,055 | - |
| 366 | SEER | Seer, Inc. | 94.50M | -0.89% | 123,387 | 16.58M |
| 367 | ANIX | Anixa Biosciences, Inc. | 91.87M | 0.37% | 65,298 | - |
| 368 | SPRB | Spruce Biosciences, Inc. | 90.57M | 3.71% | 84,061 | 697.00K |
| 369 | LONA | LeonaBio, Inc. | 89.61M | -0.42% | 24,479 | - |
| 370 | VANI | Vivani Medical, Inc. | 88.03M | -1.89% | 44,657 | - |
| 371 | GOSS | Gossamer Bio, Inc. | 87.21M | 6.97% | 8,207,987 | 48.47M |
| 372 | INO | Inovio Pharmaceuticals, Inc. | 85.67M | -3.67% | 2,919,750 | 65.34K |
| 373 | AARD | Aardvark Therapeutics, Inc. | 85.08M | -0.76% | 132,241 | - |
| 374 | PLRX | Pliant Therapeutics, Inc. | 83.89M | -0.37% | 213,222 | - |
| 375 | MCRB | Seres Therapeutics, Inc. | 83.50M | -0.57% | 12,006 | 789.00K |
| 376 | FLNA | Filana Therapeutics, Inc. | 83.09M | 1.18% | 281,952 | - |
| 377 | OKYO | OKYO Pharma Limited | 82.92M | -0.63% | 82,326 | - |
| 378 | PYPD | PolyPid Ltd. | 82.06M | 1.65% | 13,903 | - |
| 379 | NRXS | NeurAxis, Inc. | 81.11M | 2.11% | 107,212 | 3.57M |
| 380 | CSBR | Champions Oncology, Inc. | 79.85M | -4.64% | 10,222 | 57.95M |
| 381 | ESLA | Estrella Immunopharma, Inc. | 78.93M | -3.65% | 130,818 | - |
| 382 | COEP | Coeptis Therapeutics Holdings, Inc. | 78.54M | 16.31% | 86,886 | 1.36M |
| 383 | RANI | Rani Therapeutics Holdings, Inc. | 77.78M | -6.15% | 1,340,446 | 1.63M |
| 384 | GANX | Gain Therapeutics, Inc. | 77.73M | 2.22% | 345,152 | - |
| 385 | FBIO | Fortress Biotech, Inc. | 77.29M | 3.90% | 193,553 | 63.26M |
| 386 | CGTX | Cognition Therapeutics, Inc. | 76.86M | -2.27% | 697,915 | - |
| 387 | IBO | Impact BioMedical Inc. | 76.55M | - | 130,243 | 32.00K |
| 388 | IBIO | iBio, Inc. | 76.00M | -1.79% | 524,221 | 300.00K |
| 389 | PTHS | Pelthos Therapeutics Inc. | 75.77M | -1.40% | 3,265 | 16.80M |
| 390 | NRXP | NRx Pharmaceuticals, Inc. | 74.66M | 0.44% | 393,628 | 1.23M |
| 391 | GUTS | Fractyl Health, Inc. | 74.53M | 1.01% | 784,249 | 3.00K |
| 392 | IFRX | InflaRx N.V. | 74.46M | 8.42% | 705,365 | 34.44K |
| 393 | ACET | Adicet Bio, Inc. | 73.74M | 4.73% | 240,180 | - |
| 394 | ATYR | aTyr Pharma, Inc. | 73.54M | -6.23% | 1,205,702 | 190.00K |
| 395 | MAIA | MAIA Biotechnology, Inc. | 72.81M | -3.23% | 961,351 | - |
| 396 | BYSI | BeyondSpring Inc. | 72.78M | 0.57% | 7,834 | 1.88M |
| 397 | QTTB | Q32 Bio Inc. | 71.98M | -10.05% | 350,783 | 53.74M |
| 398 | XBIT | XBiotech Inc. | 71.04M | -0.43% | 24,184 | - |
| 399 | PMVP | PMV Pharmaceuticals, Inc. | 70.93M | 6.40% | 264,406 | - |
| 400 | MNOV | MediciNova, Inc. | 69.89M | -0.69% | 9,747 | 409.66K |
| 401 | CING | Cingulate Inc. | 69.31M | 1.88% | 241,760 | - |
| 402 | ATHE | Alterity Therapeutics Limited | 69.08M | -1.39% | 11,748 | 4.43M |
| 403 | DWTX | Dogwood Therapeutics, Inc. | 66.14M | 2.06% | 50,083 | - |
| 404 | ICCC | ImmuCell Corporation | 65.05M | 12.70% | 84,260 | 27.64M |
| 405 | TCRX | TScan Therapeutics, Inc. | 60.32M | - | 667,566 | 10.33M |
| 406 | ACRV | Acrivon Therapeutics, Inc. | 60.05M | 1.31% | 762,489 | - |
| 407 | PDSB | PDS Biotechnology Corporation | 59.72M | 8.08% | 1,616,489 | - |
| 408 | OKUR | OnKure Therapeutics, Inc. | 58.52M | -2.28% | 296,523 | - |
| 409 | TIL | Instil Bio, Inc. | 57.00M | -1.59% | 15,463 | - |
| 410 | INKT | MiNK Therapeutics, Inc. | 56.96M | 2.87% | 20,565 | - |
| 411 | OSTX | OS Therapies Incorporated | 56.75M | 8.00% | 1,334,467 | - |
| 412 | GRCE | Grace Therapeutics, Inc. | 56.02M | 1.40% | 575,017 | - |
| 413 | HYFT | MindWalk Holdings Corp. | 55.63M | - | 203,699 | 20.70M |
| 414 | KZR | Kezar Life Sciences, Inc. | 54.18M | -0.41% | 43,612 | - |
| 415 | IMA | ImageneBio, Inc. | 53.69M | 5.03% | 17,997 | 800.00K |
| 416 | ENTX | Entera Bio Ltd. | 53.15M | -2.56% | 48,439 | 42.00K |
| 417 | RADX | Radiopharm Theranostics Limited | 52.63M | 4.24% | 29,417 | 10.86M |
| 418 | EDSA | Edesa Biotech, Inc. | 52.60M | -0.67% | 172,915 | - |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 52.29M | - | 130,428 | 25.21M |
| 420 | MREO | Mereo BioPharma Group plc | 51.08M | 0.25% | 1,034,649 | 500.00K |
| 421 | XLO | Xilio Therapeutics, Inc. | 49.50M | -1.50% | 10,140 | 43.77M |
| 422 | ALGS | Aligos Therapeutics, Inc. | 49.32M | -0.25% | 11,391 | 2.19M |
| 423 | NTRB | Nutriband Inc. | 48.50M | 1.79% | 9,104 | 2.28M |
| 424 | ANVS | Annovis Bio, Inc. | 45.94M | -29.57% | 6,674,479 | - |
| 425 | LSTA | Lisata Therapeutics, Inc. | 45.16M | - | 11,502 | 170.00K |
| 426 | ACTU | Actuate Therapeutics, Inc. | 44.82M | -1.56% | 85,575 | - |
| 427 | RNXT | RenovoRx, Inc. | 44.08M | 4.20% | 280,019 | 1.12M |
| 428 | HOWL | Werewolf Therapeutics, Inc. | 43.66M | -8.74% | 202,903 | 1.14M |
| 429 | RLYB | Rallybio Corporation | 43.43M | -0.12% | 42,323 | 858.00K |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 43.32M | -5.26% | 69,529 | - |
| 431 | RNTX | Rein Therapeutics Inc. | 42.90M | -2.55% | 49,091 | - |
| 432 | ATOS | Atossa Therapeutics, Inc. | 42.88M | 3.32% | 43,263 | - |
| 433 | IMMP | Immutep Limited | 42.65M | -8.91% | 1,016,406 | 5.28M |
| 434 | LITS | Lite Strategy, Inc. | 42.54M | 2.63% | 121,577 | - |
| 435 | SNSE | Sensei Biotherapeutics, Inc. | 40.92M | -3.72% | 56,972 | - |
| 436 | NXTC | NextCure, Inc. | 40.86M | 2.82% | 128,981 | - |
| 437 | ATRA | Atara Biotherapeutics, Inc. | 39.50M | -3.59% | 133,939 | 120.77M |
| 438 | CELU | Celularity Inc. | 39.22M | -0.73% | 12,918 | 40.58M |
| 439 | VERU | Veru Inc. | 39.00M | -4.71% | 49,564 | 16.89M |
| 440 | CRVO | CervoMed Inc. | 37.31M | -0.25% | 29,068 | 4.01M |
| 441 | HYPD | Hyperion DeFi, Inc. | 37.25M | 1.87% | 240,301 | 813.46K |
| 442 | PASG | Passage Bio, Inc. | 35.90M | 20.45% | 128,128 | - |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 35.54M | -2.56% | 88,764 | 90.00K |
| 444 | ABVC | ABVC BioPharma, Inc. | 35.33M | 0.70% | 247,475 | 797.92K |
| 445 | CVM | CEL-SCI Corporation | 34.64M | -2.51% | 52,884 | - |
| 446 | EVAX | Evaxion A/S | 34.28M | 1.23% | 24,066 | 7.53M |
| 447 | PLUR | Pluri Inc. | 34.07M | 0.89% | 994 | 1.34M |
| 448 | INMB | INmune Bio Inc. | 34.03M | -0.78% | 209,143 | 50.00K |
| 449 | LIXT | Lixte Biotechnology Holdings, Inc. | 33.69M | 1.75% | 13,381 | - |
| 450 | LGVN | Longeveron Inc. | 32.50M | -1.77% | 739,089 | 1.20M |
| 451 | BCTX | BriaCell Therapeutics Corp. | 31.99M | 2.48% | 204,602 | - |
| 452 | DYAI | Dyadic International, Inc. | 31.91M | -1.89% | 7,358 | 3.09M |
| 453 | APLM | Apollomics, Inc. | 31.88M | -3.57% | 2,544 | 6.93M |
| 454 | PTN | Palatin Technologies, Inc. | 30.80M | -5.41% | 14,840 | 8.96M |
| 455 | MRKR | Marker Therapeutics, Inc. | 29.18M | 19.86% | 847,364 | 3.55M |
| 456 | KYNB | Kyntra Bio, Inc. | 29.10M | -1.51% | 12,577 | 6.44M |
| 457 | IGC | IGC Pharma, Inc. | 28.84M | 7.50% | 1,276,916 | 1.11M |
| 458 | CUE | Cue Biopharma, Inc. | 28.60M | 6.98% | 11,459,882 | 27.47M |
| 459 | TVRD | Tvardi Therapeutics, Inc. | 27.77M | -2.95% | 35,446 | - |
| 460 | SNTI | Senti Biosciences, Inc. | 26.95M | 1.54% | 90,545 | 22.00K |
| 461 | DARE | Daré Bioscience, Inc. | 26.94M | - | 52,176 | 1.03M |
| 462 | PSTV | Plus Therapeutics, Inc. | 26.90M | 23.66% | 849,597 | 5.21M |
| 463 | XCUR | Exicure, Inc. | 26.13M | 1.74% | 8,690 | 500.00K |
| 464 | NRSN | NeuroSense Therapeutics Ltd. | 25.81M | 1.25% | 134,621 | - |
| 465 | BOLD | Boundless Bio, Inc. | 25.66M | -0.43% | 97,772 | - |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 25.45M | 0.43% | 45,151 | 14.99M |
| 467 | SER | Serina Therapeutics, Inc. | 24.63M | -0.99% | 86,866 | 130.00K |
| 468 | TVGN | Tevogen Bio Holdings Inc. | 24.40M | 0.86% | 24,686 | - |
| 469 | SKYE | Skye Bioscience, Inc. | 24.23M | 2.63% | 80,040 | - |
| 470 | OTLK | Outlook Therapeutics, Inc. | 23.25M | -11.16% | 4,741,290 | 205.70K |
| 471 | JSPR | Jasper Therapeutics, Inc. | 23.06M | 16.48% | 1,332,308 | - |
| 472 | NNVC | NanoViricides, Inc. | 22.89M | -3.64% | 169,416 | - |
| 473 | TPST | Tempest Therapeutics, Inc. | 22.66M | 1.28% | 111,102 | - |
| 474 | LEXX | Lexaria Bioscience Corp. | 22.52M | -5.27% | 75,095 | 522.00K |
| 475 | BRNS | Barinthus Biotherapeutics plc | 22.47M | -6.65% | 9,839 | 14.97M |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 22.02M | 1.04% | 168,269 | 789.00K |
| 477 | AEON | AEON Biopharma, Inc. | 21.00M | -7.78% | 67,439 | - |
| 478 | LTRN | Lantern Pharma Inc. | 20.96M | -3.61% | 267,332 | - |
| 479 | QNTM | Quantum BioPharma Ltd. | 20.84M | -11.14% | 203,167 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 20.41M | 0.41% | 38,594 | 570.00K |
| 481 | CRIS | Curis, Inc. | 20.39M | -6.58% | 761,567 | 9.44M |
| 482 | COCP | Cocrystal Pharma, Inc. | 19.71M | -0.69% | 545,062 | - |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 18.86M | 1.58% | 252,332 | 3.94M |
| 484 | ALLR | Allarity Therapeutics, Inc. | 18.19M | -0.86% | 42,395 | 320.00K |
| 485 | KTTA | Pasithea Therapeutics Corp. | 17.96M | -6.01% | 2,625,728 | - |
| 486 | PLRZ | Polyrizon Ltd. | 17.44M | -4.87% | 18,070 | - |
| 487 | OSRH | OSR Holdings, Inc. | 16.92M | 3.80% | 1,622,347 | 2.91M |
| 488 | ICU | SeaStar Medical Holding Corporation | 16.21M | -2.87% | 71,833 | 1.23M |
| 489 | HIND | Vyome Holdings, Inc. | 16.14M | 7.98% | 16,344 | 319.71K |
| 490 | GNTA | Genenta Science S.p.A. | 16.02M | -4.03% | 32,742 | - |
| 491 | LPCN | Lipocine Inc. | 15.26M | -1.88% | 808,141 | 1.98M |
| 492 | PHIO | Phio Pharmaceuticals Corp. | 14.52M | -3.85% | 60,628 | - |
| 493 | INTS | Intensity Therapeutics, Inc. | 14.23M | 1.82% | 9,077 | - |
| 494 | INAB | IN8bio, Inc. | 14.08M | -1.38% | 52,728 | - |
| 495 | JUNS | Jupiter Neurosciences, Inc. | 13.91M | 2.93% | 71,224 | 21.80K |
| 496 | MBRX | Moleculin Biotech, Inc. | 13.61M | 4.94% | 111,939 | - |
| 497 | CYCN | Cyclerion Therapeutics, Inc. | 13.35M | 9.34% | 2,132,606 | 2.07M |
| 498 | BCDA | BioCardia, Inc. | 12.80M | -3.31% | 82,684 | 3.00K |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | 12.46M | 2.47% | 15,292 | - |
| 500 | GTBP | GT Biopharma, Inc. | 12.32M | -3.56% | 879,023 | - |